Dunn Edmund bought GLUE

March 2, 2026 · Form 4 insider transaction

Dunn Edmund bought 536 shares of Monte Rosa Therapeutics, Inc. at $13.41 per share, a transaction worth $7.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.